Imatinib attenuates neurobehavioral deficits and hippocampal neuronal damage after global cerebral ischemia in gerbils
Indian Journal of Pharmacology · 2025
DOI: 10.4103/ijp.ijp_726_23 ↗Kurz gefasst
Fachartikel in der Zeitschrift Indian Journal of Pharmacology, 2025. Verfasst von Hina Lateef Nizami und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, Molecular Neuropharmacology Laboratory, National Institute of Pharmaceutical Education and Research, Sahib…. Hauptthemen laut MEDLINE: Imatinib Mesylate, Brain Ischemia, Neuroprotective Agents, Hippocampus. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).
Abstract (Originalsprache)
Imatinib mesylate, a selective tyrosine kinase inhibitor, exhibited beneficial effects against various neurological diseases besides its anticancer activity. However, its effects on global cerebral ischemia in gerbils remain to be investigated. Global cerebral ischemia was induced by bilateral carotid artery occlusion (BCAO) in male Mongolian gerbils. Imatinib (3, 10, and 30 mg/kg BW) was administered intraperitoneally (i.p.) 30 min before BCAO. Imatinib (3 and 10 mg/kg) significantly ameliorated neurological deficits, locomotor hyperactivity, and cognitive deficits (Y-maze spontaneous alternations) at 4, 24, and 72 h, respectively, after reperfusion in gerbils. Imatinib caused reduction in neuronal cell death in CA1 hippocampal region of gerbils after BCAO and was associated with abrogation of elevated immunoreactivity of endoplasmic reticulum (ER) stress markers (GRP78 and CHOP). This study demonstrates the neuroprotective effect along with functional improvement by imatinib in global cerebral ischemia in gerbils that may be due to mitigation of ER stress.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Toxicology, Molecular Neuropharmacology Laboratory, National Institute of Pharmaceutical Education and Research, Sahibzada Ajit Singh Nagar, Punjab, India.
- Department of Applied Biology, CSIR-Indian Institute of Chemical Technology, Hyderabad, Telangana, India.
Zitieren
APA
Nizami, H. L., Srinivasan, K., & Sharma, S. S. (2025). Imatinib attenuates neurobehavioral deficits and hippocampal neuronal damage after global cerebral ischemia in gerbils. Indian Journal of Pharmacology. https://doi.org/10.4103/ijp.ijp_726_23
Vancouver
Nizami HL, Srinivasan K, Sharma SS. Imatinib attenuates neurobehavioral deficits and hippocampal neuronal damage after global cerebral ischemia in gerbils. Indian Journal of Pharmacology. 2025. doi:10.4103/ijp.ijp_726_23
BibTeX
@article{Nizami2025,
author = {Nizami, Hina Lateef and Srinivasan, Krishnamoorthy and Sharma, Shyam Sunder},
title = {Imatinib attenuates neurobehavioral deficits and hippocampal neuronal damage after global cerebral ischemia in gerbils},
journal = {Indian Journal of Pharmacology},
year = {2025},
doi = {10.4103/ijp.ijp_726_23}
}
EUVIMED